Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Comprehensive Genomic Characterization of Refractory Multiple Myeloma Reveals a Complex Mutational and Structural Landscape Associated with Drug Resistance

Nicola Lehners, MD, Umut H Toprak, Jing Xu, Nagarajan Paramasivam, Daniel Hübschmann, Martina Fröhlich, Nur H Md Hanafiah, Sadaf Mughal, Elias K Mai, MD, Anna Jauch, Jens Hillengass, MD, Roland Eils, Carsten Müller-Tidow, Benedikt Brors, Hartmut Goldschmidt, MD, Matthias Schlesner, Marc S Raab, MD PhD

Blood (2017) 130 (Supplement 1): 266.

https://doi.org/10.1182/blood.V130.Suppl_1.266.266

Published: 2017

Journal Articles

IKZF1/3 and CRL4 CRBN E3 Ubiquitin Ligase Mutations Associate with IMiD Resistance in Relapsed Multiple Myeloma

Santiago Barrio Garcia, PhD, Matteo Da Via', MD, Andoni Garitano-Trojaola, PhD, Yanira Ruiz-Heredia, Max Bittrich, MD, ChangXin Shi, PhD, Yuan Zhu, Nicola Lehners, MD, Elias K Mai, MD, Marc S Raab, MD PhD, Pieter Sonneveld, MDPhD, Joaquín Martínez, Andreas Rosenwald, Esteban Braggio, PhD, Hermann Einsele, A. Keith Stewart, MBChB, MBA, K. Martin Kortüm, MD

Blood (2017) 130 (Supplement 1): 270.

https://doi.org/10.1182/blood.V130.Suppl_1.270.270

Published: 2017

Journal Articles

Prognostic Impact of Extranodal Involvement in Newly Diagnosed Diffuse Large B-Cell Lymphoma

David Kasouha, Nicola Lehners, MD, Katharina Kriegsmann, MD MBA, Gerlinde Egerer, Anthony D. Ho, Mathias Witzens-Harig, MD MHBA

Blood (2017) 130 (Supplement 1): 2855.

https://doi.org/10.1182/blood.V130.Suppl_1.2855.2855

Published: 2017

Journal Articles

Preclinical Evaluation of Hdp-101, a Novel Anti-BCMA Antibody-Drug Conjugate, in Multiple Myeloma

Jonathan Ko, Christian Breunig, Vianiuhini Figueroa, Nicola Lehners, MD, Anja Baumann, Aniko Pálfi, Christoph Müller, Christian Lutz, Torsten Hechler, Michael Kulke, Carsten Müller-Tidow, Hartmut Goldschmidt, MD, Andreas Pahl, Marc S Raab, MD PhD

Blood (2017) 130 (Supplement 1): 3070.

https://doi.org/10.1182/blood.V130.Suppl_1.3070.3070

Published: 2017

Journal Articles

Analysis of Risk Factors Regarding Short- and Long-Term Mortality of Critically Ill Patients with Hematologic Malignancies or Following Stem Cell Transplantation Requiring Treatment on the Intensive Care Unit

Timo Funk, Martin Schiller, Gerlinde Egerer, Carsten Müller-Tidow, Anthony D. Ho, Uta Merle, Nicola Lehners, MD

Blood (2017) 130 (Supplement 1): 1947.

https://doi.org/10.1182/blood.V130.Suppl_1.1947.1947

Published: 2017

Journal Articles

Parainfluenza Virus Infections in Patients with Hematologic Malignancies or Following Stem Cell Transplantation: Analysis of Clinical Characteristics, Nosocomial Transmission and Prolonged Viral Shedding

Nicola Lehners, MD, Joe Puthenparambil, MD, Martin Schiller, MD, Anthony D. Ho, MD, Paul Schnitzler, MD, Gerlinde Egerer, MD

Blood (2016) 128 (22): 3401.

https://doi.org/10.1182/blood.V128.22.3401.3401

Published: 2016

Journal Articles

Oncogene Induced Senescence As a Potential Breakpoint Mechanism Against Malignant Transformation in Plasma Cell Disorders

Nicola Lehners, MD, Elena Ellert, MD, Jing Xu, Hartmut Goldschmidt, MD, Mindaugas Andrulis, MD, Marc S. Raab, MD

Blood (2016) 128 (22): 4474.

https://doi.org/10.1182/blood.V128.22.4474.4474

Published: 2016

Journal Articles

Analysis of Long-Term Survival in Multiple Myeloma Patients after First-Line Autologous Stem Cell Transplantation: Impact of Clinical Risk Factors and Duration of Response

Nicola Lehners, MD, Natalia Becker, PhD, Axel Benner, Maria Pritsch, Elias Karl Mai, MD, Jens Hillengass, MD, Hartmut Goldschmidt, MD, Marc S. Raab, MD

Blood (2016) 128 (22): 4649.

https://doi.org/10.1182/blood.V128.22.4649.4649

Published: 2016

Journal Articles

ATG and Statins Reduce Incidence of Severe Chronic Gvhd By Distinct Mechanisms Involving CXCL9 and Kynurenine Catabolism

Thomas Luft, MD PhD, Katharina Schmidt, MD, Karl-Heinz Kellner, PhD, Aleksandar Radujkovic, MD, Nicola Lehners, MD, Mark-Alexander Schwarzbich, MD, Ute Hegenbart, MD, Anthony D. Ho, MD, Peter Dreger, MD

Blood (2015) 126 (23): 856.

https://doi.org/10.1182/blood.V126.23.856.856

Published: 2015

Journal Articles

Analysis of Prognostic Factors and Outcome of Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma of the Gastrointestinal Tract

Nicola Lehners, MD, Isabelle Kraemer, MD, Ronald Koschny, MD, Gerlinde Egerer, MD, Anthony D. Ho, MD, Mathias Witzens-Harig, MD

Blood (2015) 126 (23): 3964.

https://doi.org/10.1182/blood.V126.23.3964.3964

Published: 2015

Journal Articles

Signaling Pathway Profiling in Multiple Myeloma

Marc S Raab, MD, Jing Xu, MSc, Thomas Hielscher, Nicola Lehners, MD, Elena Ellert, MD, Anthony D. Ho, MD FRCPC, Peter Schirmacher, MDPhD, Hartmut Goldschmidt, MD, Mindaugas Andrulis, MD

Blood (2014) 124 (21): 644.

https://doi.org/10.1182/blood.V124.21.644.644

Published: 2014

Journal Articles

Rituximab, Age and High Dose Therapy Followed By Autologus Stem Cell Transplantation Are Independent Prognostic Factors for Survival in the First Line Treatment of Primary CNS-Lymphoma

Michael Madle, Isabelle Herth, Nicola Lehners, MD, Mark-Alexander Schwarzbich, MD, Patrick Wuchter, Gerlinde Egerer, MD, Anthony D. Ho, Mathias Witzens-Harig, MD

Blood (2014) 124 (21): 1727.

https://doi.org/10.1182/blood.V124.21.1727.1727

Published: 2014

Journal Articles

Prediction of Chronic Lung Graft-Versus-Host Disease By Angiopoietin-2

Katharina Schmidt, MD, Mark-Alexander Schwarzbich, MD, Nicola Lehners, MD, Sivaramakrishna P. Rachakonda, PhD, Christine Falk, Anthony D. Ho, Prof., MD FRCPC, Peter Dreger, MD, Thomas Luft, MD PhD

Blood (2014) 124 (21): 1175.

https://doi.org/10.1182/blood.V124.21.1175.1175

Published: 2014

Journal Articles

Female Donors Are Associated with an Increased Risk of Chronic Graft-Versus-Host Disease (cGVHD) Independent of Recipient Sex but Provide Superior Graft-Versus-Leukemia Activity Once cGVHD Is Established

Nicola Lehners, MD, Mark-Alexander Schwarzbich, MD, Katharina Schmidt, MD, Joe Puthenparambil, MD, Aleksandar Radujkovic, MD, Sascha Dietrich, MD, Anthony D Ho, MD, Peter Dreger, MD, Thomas Luft, MD PhD

Blood (2014) 124 (21): 3917.

https://doi.org/10.1182/blood.V124.21.3917.3917

Published: 2014

Journal Articles

Impact Of Response Duration and Maintenance Therapy After Autologous Stem Cell Transplantation On Long-Term Survival In Multiple Myeloma Patients

Nicola Lehners, MD, Christiane Heiss, Soh-Yun Kim, Thomas Hielscher, Jens Hillengass, MD, Gerlinde Egerer, MD, Anthony D. Ho, MD, Kai Neben, MD, Hartmut Goldschmidt, MD, Marc S. Raab, MD

Blood (2013) 122 (21): 3183.

https://doi.org/10.1182/blood.V122.21.3183.3183

Published: 2013

Journal Articles

Continued Response off Treatment After BRAF Inhibition in Refractory Hairy Cell Leukemia

Sascha Dietrich, MD, Jennifer Hüllein, Michael Hundemer, Nicola Lehners, MD, Alexander Jethwa, David Capper, MD, Till Acker, MD, Boyan Garvalov, PhD, Mindaugas Andrulis, MD, Carolin Blume, Julia Meissner, MD, Stefan Fröhling, MD, Christof von Kalle, MD, Hanno Glimm, MD, Anthony D. Ho, MD, Thorsten Zenz, MD

Blood (2012) 120 (21): 4600.

https://doi.org/10.1182/blood.V120.21.4600.4600

Published: 2012

Journal Articles

The Chromosomal Abnormalities Del(17p), t(4;14), and +1q21 Predict Progression From Smoldering to Symptomatic Multiple Myeloma

Kai Neben, MD, Anna Jauch, PhD, Thomas Hielscher, Jens Hillengass, MD, Nicola Lehners, MD, Marc S Raab, MD, Anthony D. Ho, MD, Hartmut Goldschmidt, MD, Dirk Hose, MD

Blood (2012) 120 (21): 1806.

https://doi.org/10.1182/blood.V120.21.1806.1806

Published: 2012

Journal Articles

Analysis of Prognostic Factors in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma and Skeletal Involvement: A Novel Simple Prognostic Score Identifies a Large Group of Low Risk Patients with an Excellent Prognosis

Nicola Lehners, MD, Marie-Luise Memmer, Anthony D. Ho, MD, Mathias Witzens-Harig

Blood (2012) 120 (21): 1590.

https://doi.org/10.1182/blood.V120.21.1590.1590

Published: 2012

Journal Articles

BRAF V600E Mutations in Multiple Myeloma: Clinical and Therapeutic Implications

Nicola Lehners, MD, Mindaugas Andrulis, MD, David Capper, MD, Andreas von Deimling, MD, Anthony D Ho, MD, Hartmut Goldschmidt, MD, Kai Neben, MD, Marc S Raab, MD

Blood (2012) 120 (21): 4040.

https://doi.org/10.1182/blood.V120.21.4040.4040

Published: 2012

Journal Articles

Outbreak of Nosocomial Respiratory Syncytial Virus Infections in a Hematology and Transplant Unit.

Nicola Lehners, MD, Paul Schnitzler, MD, Gerlinde Egerer, MD, Peter Dreger, MD, Christoph Eisenbach, MD, Elisabeth Aichinger, MD, Benedikt Weißbrich, MD, Uwe Frank, MD, Klaus Heeg, MD, Anthony D Ho, MD

Blood (2012) 120 (21): 3032.

https://doi.org/10.1182/blood.V120.21.3032.3032

Published: 2012

NARROW

Comprehensive Genomic Characterization of Refractory Multiple Myeloma Reveals a Complex Mutational and Structural Landscape Associated with Drug Resistance

IKZF1/3 and CRL4 CRBN E3 Ubiquitin Ligase Mutations Associate with IMiD Resistance in Relapsed Multiple Myeloma

Prognostic Impact of Extranodal Involvement in Newly Diagnosed Diffuse Large B-Cell Lymphoma

Preclinical Evaluation of Hdp-101, a Novel Anti-BCMA Antibody-Drug Conjugate, in Multiple Myeloma

Analysis of Risk Factors Regarding Short- and Long-Term Mortality of Critically Ill Patients with Hematologic Malignancies or Following Stem Cell Transplantation Requiring Treatment on the Intensive Care Unit

Parainfluenza Virus Infections in Patients with Hematologic Malignancies or Following Stem Cell Transplantation: Analysis of Clinical Characteristics, Nosocomial Transmission and Prolonged Viral Shedding

Oncogene Induced Senescence As a Potential Breakpoint Mechanism Against Malignant Transformation in Plasma Cell Disorders

Analysis of Long-Term Survival in Multiple Myeloma Patients after First-Line Autologous Stem Cell Transplantation: Impact of Clinical Risk Factors and Duration of Response

ATG and Statins Reduce Incidence of Severe Chronic Gvhd By Distinct Mechanisms Involving CXCL9 and Kynurenine Catabolism

Analysis of Prognostic Factors and Outcome of Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma of the Gastrointestinal Tract

Signaling Pathway Profiling in Multiple Myeloma

Rituximab, Age and High Dose Therapy Followed By Autologus Stem Cell Transplantation Are Independent Prognostic Factors for Survival in the First Line Treatment of Primary CNS-Lymphoma

Prediction of Chronic Lung Graft-Versus-Host Disease By Angiopoietin-2

Female Donors Are Associated with an Increased Risk of Chronic Graft-Versus-Host Disease (cGVHD) Independent of Recipient Sex but Provide Superior Graft-Versus-Leukemia Activity Once cGVHD Is Established

Impact Of Response Duration and Maintenance Therapy After Autologous Stem Cell Transplantation On Long-Term Survival In Multiple Myeloma Patients

Continued Response off Treatment After BRAF Inhibition in Refractory Hairy Cell Leukemia

The Chromosomal Abnormalities Del(17p), t(4;14), and +1q21 Predict Progression From Smoldering to Symptomatic Multiple Myeloma

Analysis of Prognostic Factors in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma and Skeletal Involvement: A Novel Simple Prognostic Score Identifies a Large Group of Low Risk Patients with an Excellent Prognosis

BRAF V600E Mutations in Multiple Myeloma: Clinical and Therapeutic Implications

Outbreak of Nosocomial Respiratory Syncytial Virus Infections in a Hematology and Transplant Unit.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only